US 12060346
Inhibitors of APOL1 and methods of using same
granted A61PA61P13/12
Quick answer
US patent 12060346 (Inhibitors of APOL1 and methods of using same) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 53
- CPC classes
- A61P, A61P13/12